Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-
-

Import Operations Branch

Our mission is to promote and protect the public health by ensuring human drug importation and exportation adhere to FDA's standards of compliance. More specifically to:

  • Serve as FDA focal point at CDER for all human drug import and export compliance issues.
  • Promote goodwill and cooperation between the United States and foreign governments through the Export Certificate Program.
  • Assure the integrity of imported and exported drugs by monitoring investigational and unapproved new drugs.

     

 For General Imports Compliance
questions, Contact:

CDERImportsExports@fda.hhs.gov

 For Export Certificate and Compliance questions, Contact:

CDERExportCertificateProgram@fda.hhs.gov

 

 

 

 

 

On this page:
 
 
Drug Imports
Import Guidance and Policy
Compliance Communications
Import Requirements for Specific Drugs
Pre-Launch Activities Importation Requests (PLAIR)
Imports for Human Drug Pharmacy Compounding

Personal Importation Policy (PIP)

Drug Exports
The FDA CDER Export Certificate Program is responsible for the issuance of Certificates of Pharmaceutical Product (CPP). In connection with the issuance of CPPs, we review the regulatory status of the manufacturing establishments, compliance with cGMPs, labeling, listings/registrations, and marketing authority.
Presentations
Other Resources
 
-
-
-